TCL Archive Cancer Epidemiology Hampered By Bureaucratic Delays, Lack of Cooperation, NCI Group Says September 29, 1978
TCL Archive In Brief: Weicker Joins Tobacco Company Board; Hatfield To Leave Senate Next Year December 8, 1995
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
